Nan Fung Group Holdings’s DBV Technologies S.A. American Depositary Shares DBVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-37,095
Closed -$253K – 23
2025
Q1
$253K Hold
37,095
– – 0.21% 32
2024
Q4
$115K Hold
37,095
– – 0.1% 33
2024
Q3
$130K Hold
37,095
– – 0.11% 35
2024
Q2
$149K Hold
37,095
– – 0.16% 41
2024
Q1
$278K Hold
37,095
– – 0.26% 37
2023
Q4
$353K Hold
37,095
– – 0.22% 30
2023
Q3
$504K Hold
37,095
– – 0.41% 27
2023
Q2
$705K Hold
37,095
– – 0.45% 27
2023
Q1
$627K Hold
37,095
– – 0.43% 28
2022
Q4
$568K Hold
37,095
– – 0.39% 24
2022
Q3
$657K Hold
37,095
– – 0.42% 23
2022
Q2
$946K Hold
37,095
– – 0.65% 19
2022
Q1
$590K Hold
37,095
– – 0.28% 29
2021
Q4
$594K Hold
37,095
– – 0.18% 33
2021
Q3
$1.82M Buy
37,095
+8,545
+30% +$441K 0.58% 16
2021
Q2
$1.56M Buy
+28,550
New +$1.71M 0.48% 18

Other funds holding DBVT

Nan Fung Group Holdings's DBVT Position: Q2 2025 in Review

Nan Fung Group Holdings sold out of DBV Technologies S.A. American Depositary Shares (DBVT) in Q2 2025, closing a stake of 37,095 shares — an estimated $253K sold.

Nan Fung Group Holdings first reported a position in DBVT in Q2 2021 and held it in 16 quarters. The position peaked at $1.82M in Q3 2021. 29 funds tracked by Wall St. Rank hold DBVT as of Q2 2025.

  • Nan Fung Group Holdings reported no remaining DBV Technologies S.A. American Depositary Shares position as of Q2 2025 after selling out during the quarter.
  • Nan Fung Group Holdings sold 37,095 DBV Technologies S.A. American Depositary Shares shares in Q2 2025, an estimated $253K.
  • Nan Fung Group Holdings first reported a position in DBV Technologies S.A. American Depositary Shares in Q2 2021 and held it in 16 quarters.
  • Nan Fung Group Holdings's DBV Technologies S.A. American Depositary Shares position peaked at $1.82M in Q3 2021.
  • 29 funds tracked by Wall St. Rank held DBV Technologies S.A. American Depositary Shares as of Q2 2025.

Based on Nan Fung Group Holdings's 13F filing for Q2 2025, filed 13 Aug 2025.